Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
From Hematologic Oncology Update by Dr. Neil Love
April 20, 2026 · 59 min · Season 25 · Episode 75
About this episode
Dr Amir Fathi and Dr Eunice S Wang discuss key clinical trial data on menin inhibitors for AML management.
Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML. CME information and select publications here .
People in this episode
Host: Dr Neil Love
Guests: Dr Amir Fathi, Dr Eunice S Wang
Topics covered
- Acute Myeloid Leukemia
- clinical trials
- menin inhibitors
- cancer management
- medical advancements
Keywords
- Acute Myeloid Leukemia
- menin inhibitors
- clinical trials
- cancer treatment
- medical research
Mentioned in this episode
Organizations: Massachusetts General Hospital, Roswell Park Comprehensive Cancer Center
Places: Boston, Massachusetts, Buffalo, New York
More episodes of Hematologic Oncology Update
- Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances · May 23, 2026 · 59 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson · April 10, 2026 · 25 min
- Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review · April 1, 2026 · 25 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson · March 23, 2026 · 24 min
- Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review · March 21, 2026 · 29 min
- CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah · March 13, 2026 · 1h 3m
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.